High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism

American Journal of Physiology - Renal Physiology

Volumn 284, Issue 3 53-3, 2003, Pages

  Kang, Barinder P S ^a   Frencher, Stanley ^a   Reddy, Venkatesh ^a   Kessler, Alex ^a   Malhorta, Ashwani ^a   Meggs, Leonard G ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Mesangial cell; Mitochondria; Nuclear fator B; Reactive oxygen species; Superoxide anion

Indexed keywords

CASPASE; CYTOCHROME C; GLUCOSE; HYDROGEN PEROXIDE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0037369416     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00137.2002     Document Type: Article

References (48)

1. Akao M, Ohler A, O'Rourke B, and Marban E. Mitochondrial sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res 88: 1267-1275, 2001.
2. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, and Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellualrity in mesangial proliferative nephritis. J Clin Invest 94: 2105-2116, 1994.
3. Baynes J and Thorpe S. The role of oxidative stress in diabetic complications: a new perspective of an old paradigm. Diabetes 48: 1-19, 1999.
4. Bendtsen TF and Nyengaard JR. The number of glomeruli in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 35: 844-850, 1992.
5. Collins T and Cybulsky MI. NF-KB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107: 255-264, 2001.
6. 2+ superoxide dismutase protects against early diabetic glomerular injury. Diabetes 50: 2114-2125, 2001.
7. a.The diabetes control, and complications trail research group. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
8. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, and Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50: 2363-2375, 2001.
9. Fiordaliso F, Li B, Latini R, Sonenblick EH, Anversa P, Leri A, and Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II dependent. Lab Invest 80: 513-527, 2000.
10. Forbes RA, Steenbergen C, and Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88: 802-809, 2001.
11. Gotlieb RA, Burleson KO, Kloner RA, Babior BM, and Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
12. Green DR and Reed JC. Mitochondria and apoptosis. Science 281:1309-1312, 1998.
13. Guigliano DA, Ceriello A, and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996.
14. Hain S. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in red blood cells. J Biol Chem 264: 21340-21345, 1989.
15. Hall JF, Matter CM, Wang X, and Gibbons GH. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circ Res 87: 574-580, 2000.
16. Haugland RP. Handbook of Fluorescent Probes and Research Products (9th ed.). Eugene, OR: Molecular Probes, 2002, p. 749.
17. Haunstetter A and Izumo S. Apoptosis basic mechanisms and implications for cardiovascular disease. Circ Res 82: 1111-1129, 1998.
18. Ishikawa Y, Yokoo T, and Kitamura M. C-JUN/AP-1, but not NF-κB, is a mediator of oxidant-initiated apoptosis in glomerular mesangial cells. Biochem Biophys Res Commun 240: 496-501, 1997.
19. Jaimes EA, Galceran JM, and Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998.
20. Karin M and Ben-Neriah Y. Phosphorylation meets ubiquination: the control of NF-κB activity. Annu Rev Immunol 18: 621-663, 2000.
21. Kirch HC, Flaswinkel S, Rumpf H, Brockmann D, and Esche H. Expression of human p53 requires synergistic activation of the p53 promoter by AP-1, NF-κB and Myc/Max. Oncogene 18: 2728-2738, 1999.
22. Lando D, Pongratz I, and Whitelaw ML. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1α and the HIF-like factor. J Biol Chem 275: 4618-4627, 2000.
23. Lawrence T, Gilroy DW, Coville-Nash PR, and Willoughby DA. Possible new role for NF-κB in the resolution of inflammation. Nat Med 7: 1291-1297, 2001.
24. Leri A, Yu L, Wang X, Kajstura J, Malhotra A, Meggs LG, and Anversa P. Overexpression of insulin like growth factor-1 attenuates the myocyte renin angiotensin system in transgenic mice. Circ Res 84: 752-762, 1999.
25. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, and Striker GE. Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int 33: 677-684, 1988.
26. Mogensen CE and Andersen MF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706-712, 1973.
27. Mooney A, Jobson T, Bacon R, Kitamura M, and Savill J. Cytokines promote glomerular mesangial cell survival in vitro by stimulus dependent inhibition of apoptosis. J Immunol 159: 3949-3960, 1997.
28. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide overproduction blocks three pathways of hyperglycemic damage. Nature 404: 787-790, 2000.
29. Osterby R. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35: 803-812, 1992.
30. Osterby R, Schmitz A, and Nyberg G. Renal structural changes in insulin-dependent diabetic patients with albuminuria: comparison of cases with the onset of albuminuria after short or long duration. APMIS 106: 361-370, 1998.
31. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, and Baserga R. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19: 7203-7215, 1999.
32. Phillips SL, DeRubertis R, and Craven PA. Regulation of the laminin C1 promoter in cultured mesangial cells. Diabetes 48:2083-2089, 1999.
33. Ryan K, Ernst M, Rice N, and Vousden K. Role of NF-κB in p53 mediated program cell death. Nature 404: 892-897, 2000.
34. Sandau K, Pfeilschifter J, and Brune B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int 52: 378-386, 1997.
35. Schenk H, Klien M, Erdbrugger W, Droge W, and Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 91: 1672-1676, 1994.
36. Sharma P, Reddy K, Franki N, Sanwal V, Sankaran R, Ahuja TS, Gibbons N, Mattana J, and Singhal PC. Native and oxidized low density lipoproteins modulate mesangial cell apoptosis. Kidney Int 50: 1604-1611, 1996.
37. Singhal PC, Franki N, Kumari S, Sanwal V, Wagner JD, and Mattana J. Extracellular matrix modulates mesangial cell apoptosis and mRNA expression of cathepsin B and tissue transglutaminase. J Cell Biochem 68: 22-30, 1998.
38. Singhal PC, Gibbons N, Franki N, Reddy K, Sharma P, Mattana J, Wagner JD, and Bansal V. Simulated glomerular hypertension promotes mesangial cell apoptosis and expression of cathepsin-B and SGP-2. J Investig Med 46: 42-50, 1998.
39. Steffes M, Schmidt D, McCrery R, and Basgen JM. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113, 2001.
40. Sun X, Shimizu H, and Yamamoto KI. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 expression. Mol Cell Biol 15: 4489-4496, 1995.
41. Ting H, Timimi FK, and Boles KS. Vitamin C improves endothelium dependent vasodilation in patients with non insulin dependent diabetes mellitus. J Clin Invest 97: 22-28, 1996.
42. Von Harsdorf R, Li PF, and Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99: 2934-2941, 1999.
43. Wolf G, Haberstroh U, and Nielson EG. Angiotensin II stimulates the proliferation and biosynthesis of type 1 collagen in cultured murine mesangial cells. Am J Pathol 140: 95-107, 1992.
44. Wu H, and Lozano G. NF-κB activation of p53. J Biol Chem 269:20067-20074, 1994.
45. Wyllie AH, Arends MJ, Morris RG, Walker SW, and Evan G. The apoptosis endonuclease and its regulation. Semin Immunol 4: 381-387, 1992.
46. Yerneni KKV, Wei B, Khan BV, Medford RM, and Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappa B in vascular smooth muscle cells. Diabetes 50: 2363-2375, 1999.
47. Yin C, Knudson M, Korsemeyer SJ, and VanDyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640, 1997.
48. Zweier JL, Flaherty JT, and Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84: 1404-1407, 1987.